Amylyx Pharmaceuticals, Inc.
AMLX · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $0K | $87.4M | −100% |
| Operating income | −$153M | −$315M | +51.3% |
| Net income | −$145M | −$302M | +52.0% |
Questions
- What was Amylyx's revenue in FY2025?
- $0K in FY2025 (Fiscal year ended Dec 31, 2025), −100% vs $87.4M a year earlier, per its 10-K filed Mar 2026.
- Was Amylyx profitable in FY2025?
- No: net income was −$145M and operating income −$153M in FY2025.